Technical Analysis for NWBO - Northwest Bioth Cmn

Grade Last Price % Change Price Change
grade A 0.3475 -2.11% -0.0075
NWBO closed down 2.11 percent on Wednesday, July 15, 2020, on 59 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical NWBO trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.11%
20 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Spinning Top Other 0.00%
20 DMA Resistance Bearish -1.95%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.95%
Inside Day Range Contraction -1.95%
20 DMA Resistance Bearish -3.07%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.07%
Outside Day Range Expansion -3.07%
Older signals for NWBO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing immunotherapy products to treat cancer. One of the product lines (DCVax-L) is designed to cover all solid tumor cancers in which the tumors can be surgically removed. Another product line (DCVax-Direct) is designed for all solid tumor cancers. The Company's lead product, DCVax-L, is in an ongoing Phase III trial for diagnosed Glioblastome multiforme (GBM), with over 60 trial sites. Its second product, DCVax-Direct, is being studied in a 60-patient Phase I/II trial for all types of inoperable solid tumors. The 40-patient Phase I stage of the trial has been completed. The Company is working on preparations for Phase II trials of DCVax-Direct. The Company's platform technology, DCVax, uses activated dendritic cells to mobilize a patient's own immune system, including T cells, B cells and antibodies and natural killer cells, among others to attack cancer cells to attack their cancer.
Medicine Health Biotechnology RTT Cancer Clinical Medicine Antibodies Immunotherapy Cancer Immunotherapy Platform Technology Tumors Virotherapy Northwest Biotherapeutics Solid Tumor Cancers Tumor Antigen Vaccine

Is NWBO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.419
52 Week Low 0.14
Average Volume 2,478,310
200-Day Moving Average 0.2292
50-Day Moving Average 0.3108
20-Day Moving Average 0.3603
10-Day Moving Average 0.3503
Average True Range 0.0239
ADX 18.78
+DI 19.4735
-DI 16.9309
Chandelier Exit (Long, 3 ATRs ) 0.3233
Chandelier Exit (Short, 3 ATRs ) 0.3808
Upper Bollinger Band 0.3877
Lower Bollinger Band 0.3329
Percent B (%b) 0.27
BandWidth 15.2095
MACD Line 0.0079
MACD Signal Line 0.0129
MACD Histogram -0.005
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.3760
Resistance 3 (R3) 0.3770 0.3685 0.3713
Resistance 2 (R2) 0.3685 0.3612 0.3680 0.3697
Resistance 1 (R1) 0.3580 0.3568 0.3538 0.3570 0.3681
Pivot Point 0.3495 0.3495 0.3474 0.3490 0.3495
Support 1 (S1) 0.3390 0.3422 0.3348 0.3380 0.3269
Support 2 (S2) 0.3305 0.3378 0.3300 0.3253
Support 3 (S3) 0.3200 0.3305 0.3238
Support 4 (S4) 0.3190